Korean J Helicobacter  Up Gastrointest Res Search

CLOSE


Korean J Helicobacter  Up Gastrointest Res > Volume 16(3); 2016 > Article
The Korean Journal of Helicobacter  and Upper Gastrointestinal Research 2016;16(3):134-138.
DOI: https://doi.org/10.7704/kjhugr.2016.16.3.134    Published online September 10, 2016.
Vaccine Development and Future for Helicobacter pylori
Soo Jeong Cho
Center for Gastric Cancer, National Cancer Center, Goyang, Korea. crystal522@ncc.re.kr
Helicobacter pylori 백신 개발 현황과 전망
조수정
국립암센터 위암센터
Abstract
Helicobacter pylori is one of the most common gastric pathogens, affecting at least half the world's population, and is strongly associated with gastritis, peptic ulcer, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Vaccination against H. pylori has been challenging because of its low efficacy, lack of information about protective immunity, and disappointing clinical studies. A recent phase 3 clinical trial in China was reported to be successful to test prophylactic vaccination against H. pylori, which caused growing interest in the vaccine development against H. pylori. Here, we review literatures regarding vaccination against H. pylori.
Key Words: Helicobacter pylori; Vaccine


Editorial Office
Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-717-5543    Fax: +82-2-565-9947    E-mail: helicojournal@smileml.com                

Copyright © 2024 by Korean College of Helicobacter and Upper Gastrointestinal Research.

Developed in M2PI

Close layer
prev next